Latest news

• UK approval for Seagen’s oral HER2 inhibitor Tukysa

  The US Food and Drug Administration (FDA) approved Seagen’s drug as part of Project Orbis, an initiative of the US FDA Oncology Center of Excellence that provides a framework for

• AstraZeneca wins FDA approval for Calquence in chronic lymphoma

  arms. The approval was one of the first to be granted under Project Orbis, an initiative of the US FDA Oncology Center of Excellence which provides a framework for concurrent submission